(68 days)
No
The summary describes a standard electrosurgical device using RF energy for vessel sealing and division. There is no mention of AI, ML, or any related technologies in the device description, intended use, or performance studies.
Yes
The devices are intended for use in surgical procedures to ligate and divide vessels, tissue bundles, and lymphatics, which directly addresses medical conditions by sealing and cutting tissues in the body.
No
The device is described as an electrosurgical instrument intended for surgical procedures involving ligation, division, and sealing of vessels and tissues, not for diagnosing conditions.
No
The device description clearly outlines hardware components: a generator, and two types of electrosurgical instruments (Trinity and Mini) with physical shafts, jaws, and blades. These are not software-only components.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the CoolSeal™ system is for surgical procedures involving the ligation and division of vessels, tissue bundles, and lymphatics. This is a therapeutic and surgical application, not a diagnostic one.
- Device Description: The description details a generator that provides RF energy and instruments (Trinity and Mini) that apply this energy to tissue for sealing and division. This is consistent with surgical tools, not devices used to examine specimens outside the body for diagnostic purposes.
- Lack of IVD Characteristics: There is no mention of the device being used to test samples of human origin (blood, urine, tissue, etc.) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening.
In summary, the CoolSeal™ system is a surgical device used in vivo (within the body) during procedures, not an IVD used in vitro for diagnostic testing.
N/A
Intended Use / Indications for Use
CoolSeal™ Trinity:
The CoolSeal™ Trinity is a bipolar electrosurgical instrument intended for use in minimally invasive or open surgical procedures where ligation and division of vessels, tissue bundles, and lymphatics is desired. The CoolSeal™ Trinity can be used on arteries up to and including 6 mm, veins, and vascular bundles up to and including 7 mm in diameter. It is indicated for use in general surgery procedures including urologic, vascular, and gynecologic.
The CoolSeal™ Trinity has not been shown to be effective for tubal coagulation for sterilization for sterilization procedures. Do not use the CoolSeal™ Trinity for these procedures..
CoolSeal™ Mini:
The CoolSeal™ Mini is intended for use in open and laparoscopic general surgical procedures to seal blood vessels and vascular bundles up to and including 5 mm in diameter for use in adult and pediations, wherever vessel ligation is required. The device is contraindicated for use in ENT procedures.
CoolSealTM Generator:
The CoolSeal™ Generator is intended to provide Radio Frequency (RF) energy to compatible CoolSeal™ instruments for vessel-sealing applications. The specific application will depend on the compatible surgical device that is connected to the generator. This generator is designed to be used with only surgical devices compatible with the CoolSeal™ technology.
Product codes
GEI
Device Description
CoolSeal™ Generator:
The CoolSeal™ Generator is a non-sterile, reusable device used outside the sterile field. The generator is designed to provide lower power bipolar Radio Frequency (RF) energy to CoolSeal™ vessel sealing devices for tissue-sealing applications.
CoolSeal™ Trinity:
The CoolSeal™ Trinity, a Maryland Laparoscopic Sealer, Divider, and Dissector, with a 5 mm diameter shaft is designed for use with the CoolSeal™ Generator or any generator with the CoolSeal™ technology. The Trinity is provided sterile and is a single-use disposable instrument. The Trinity creates seals by application of radiofrequency (RF) electrosurgical energy to vascular structures (vessels and lymphatics) or tissue bundles interposed between its jaws. A blade within the instrument is surgeon-actuated to divide tissue. The double action jaws have been designed to dissect tissue, which includes separating tissue planes and widening openings as necessary for the surgical procedure. The CoolSeal™ Trinity includes 3 different shaft lengths: 30 cm, 37 cm, and 44 cm.
CoolSeal™ Mini:
The CoolSeal™ Mini a Maryland Jaw Sealer, with a 3 mm diameter shaft is designed for use with the CoolSeal™ Generator or any generator with the CoolSeal™ technology. The Mini is provided sterile and is a single-use disposable instrument. The Mini creates seals by application of radiofrequency (RF) electrosurgical energy to vascular structures or tissue bundles interposed between its jaws. The double-action jaws have been designed to dissect tissue, which includes separating tissue planes and widening openings as necessary for the surgical procedure. The CoolSeal™ Mini is only available in one shaft length: 20 cm.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
vessels, tissue bundles, lymphatics, arteries, veins, vascular bundles
Indicated Patient Age Range
Adult and pediatric populations for CoolSeal Mini. Not specified for CoolSeal Trinity or CoolSeal Generator.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Biocompatibility Testing:
CoolSeal™ Trinity: Evaluated in accordance with ISO 10993-1:2018.
CoolSeal™ Mini: Biocompatibility testing previously submitted for the predicate device is applicable.
Electrical Safety and Electromagnetic Compatibility (EMC):
CoolSeal™ system complies with ANSI/AAMI/ES 60601-1:2005/(R)2012 and A1:2012, IEC 60601-2-2:2017, and IEC 60601-1-2:2014 standards.
Mechanical and Functional Testing:
Mechanical, electrical, and functional testing performed to verify expected performance.
Ex-vivo and In-vivo Vessel Burst Pressure:
CoolSeal™ Trinity: Ex-vivo burst pressure testing on excised fresh porcine blood vessels and in-vivo burst pressure testing of lymphatics conducted to demonstrate equivalent bipolar electrosurgical vessel sealing performance compared to predicate.
CoolSeal™ Mini: Ex-vivo burst pressure testing on excised fresh porcine blood vessels conducted.
In-vivo Thermal Spread Comparison:
CoolSeal™ Trinity: Open laparotomy performed in a porcine model. Samples excised for three-dimensional histological assessments (length, width, and depth) to quantify thermal spread in seals created by both subject and predicate devices. Demonstrated that the subject device is as safe and effective as the predicate device.
Chronic Animal Study:
CoolSeal™ Trinity: A chronic study conducted over 28 days to assess safety and performance of bipolar vessel sealing. All animals survived 28 days post-op without complications. All vessel sealing effects on tissue maintained chronic hemostasis and healed as anticipated.
Clinical Studies:
Clinical data was not necessary to support this premarket notification as the indications for use, device technology, and mechanism of action is not significantly different when compared to the predicate devices. Nonclinical testing as described above is sufficient to establish substantial equivalence.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
October 6, 2020
Bolder Surgical, LLC % Dave Yungvirt Official Correspondent Third Party Review Group, LLC 25 Independence Blvd Warren, New Jersey 07059
Re: K202114
Trade/Device Name: CoolSeal Generator/CSL-200-50, CoolSeal Trinity (30 cm shaft)/CSL-TR105-30, CoolSeal Trinity (37 cm shaft)/CSL-TR105-37, CoolSeal Trinity (44 cm shaft)/CSL-TR105-44, CoolSeal Mini (20cm shaft)/CSL-MN103-20 Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: October 5, 2020 Received: October 6, 2020
Dear Dave Yungvirt:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of
1
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Long Chen. Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known) K202114
Device Name
CoolSeal Trinity, CoolSeal Mini, CoolSeal Generator
Indications for Use (Describe)
CoolSeal™ Trinity:
The CoolSeal™ Trinity is a bipolar electrosurgical instrument intended for use in minimally invasive or open surgical procedures where ligation and division of vessels, tissue bundles, and lymphatics is desired. The CoolSeal™ Trinity can be used on arteries up to and including 6 mm, veins, and vascular bundles up to and including 7 mm in diameter. It is indicated for use in general surgery procedures including urologic, vascular, and gynecologic.
The CoolSeal™ Trinity has not been shown to be effective for tubal coagulation for sterilization for sterilization procedures. Do not use the CoolSeal™ Trinity for these procedures..
CoolSeal™ Mini:
The CoolSeal™ Mini is intended for use in open and laparoscopic general surgical procedures to seal blood vessels and vascular bundles up to and including 5 mm in diameter for use in adult and pediations, wherever vessel ligation is required. The device is contraindicated for use in ENT procedures.
CoolSealTM Generator:
The CoolSeal™ Generator is intended to provide Radio Frequency (RF) energy to compatible CoolSeal™ instruments for vessel-sealing applications. The specific application will depend on the compatible surgical device that is connected to the generator. This generator is designed to be used with only surgical devices compatible with the CoolSeal™ technology.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | |
|---|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/2 description: The image shows the logo for Bolder Surgical. The word "BOLDER" is written in a bold, sans-serif font in blue, with a small black diamond shape incorporated into the "O". Below "BOLDER" is the word "SURGICAL" in a thinner, sans-serif font in black. The logo is clean and modern, with a focus on the company name.
CoolSeal™ System Traditional 510(k) Submission
510(k) Summary
SUBMITTER
Bolder Surgical, LLC. 331 S. 104th Street, Suite 200 Louisville, CO 80027
Phone: 720-287-7130 Fax: 720-287-7135
Contact Person: Nick Wong Regulatory Affairs Manager
Date Prepared: September 25th, 2020
DEVICES
| Trade Name / Model #: | CoolSeal™ Generator / CSL-200-50
CoolSeal™ Trinity 30 cm / CSL-TR105-30 37 cm / CSL-TR105-37 44 cm / CSL-TR105-44 CoolSeal™ Mini 20 cm / CSL-MN103-20 |
|-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common or Usual Name: | Bipolar Vessel Sealing System |
| Classification Name: | Electrosurgical cutting and coagulation device and accessories |
| Regulatory Class: | II |
| Produce Code: | GEI |
PREDICATE DEVICES
Predicate Device for the CoolSeal™ Generator: Trade Name: JustRight™ Generator 510(k): K160602
Predicate Device for the CoolSeal™ Trinity: Trade Name: LigaSure™ Maryland jaw Sealer/Divider One-Step Sealing, Nano-Coated 510(k): K170869
Predicate Device for the CoolSeal™ Mini: Trade Name: JustRight™ Sealer 510(k) K160602
REFERENCE DEVICE
Reference Device for the CoolSeal™ Trinity: Trade Name: JustRight™ Sealer
4
Image /page/4/Picture/2 description: The image shows the logo for Bolder Surgical. The word "BOLDER" is written in a bold, sans-serif font, with the "O" replaced by a circle with a small, black triangle inside. Below "BOLDER" is the word "SURGICAL" in a thinner, sans-serif font. The color of the text is a dark blue.
CoolSeal™ System Traditional 510(k) Submission
510(k) K160602
DEVICE DESCRIPTION
CoolSeal™ Generator:
The CoolSeal™ Generator is a non-sterile, reusable device used outside the sterile field. The generator is designed to provide lower power bipolar Radio Frequency (RF) energy to CoolSeal™ vessel sealing devices for tissue-sealing applications.
CoolSeal™ Trinity:
The CoolSeal™ Trinity, a Maryland Laparoscopic Sealer, Divider, and Dissector, with a 5 mm diameter shaft is designed for use with the CoolSeal™ Generator or any generator with the CoolSeal™ technology. The Trinity is provided sterile and is a single-use disposable instrument. The Trinity creates seals by application of radiofrequency (RF) electrosurgical energy to vascular structures (vessels and lymphatics) or tissue bundles interposed between its jaws. A blade within the instrument is surgeon-actuated to divide tissue. The double action jaws have been designed to dissect tissue, which includes separating tissue planes and widening openings as necessary for the surgical procedure. The CoolSeal™ Trinity includes 3 different shaft lengths: 30 cm, 37 cm, and 44 cm.
CoolSeal™ Mini:
The CoolSeal™ Mini a Maryland Jaw Sealer, with a 3 mm diameter shaft is designed for use with the CoolSeal™ Generator or any generator with the CoolSeal™ technology. The Mini is provided sterile and is a single-use disposable instrument. The Mini creates seals by application of radiofrequency (RF) electrosurgical energy to vascular structures or tissue bundles interposed between its jaws. The double-action jaws have been designed to dissect tissue, which includes separating tissue planes and widening openings as necessary for the surgical procedure. The CoolSeal™ Mini is only available in one shaft length: 20 cm.
INDICATIONS FOR USE
CoolSealTM Generator:
The CoolSeal™ Generator is intended to provide Radio Frequency (RF) energy to compatible CoolSeal™ instruments for vessel-sealing applications. The specific application will depend on the compatible surgical device that is connected to the generator. This generator is designed to be used with only surgical devices compatible with the CoolSeal™ technology.
CoolSeal™ Trinity:
The CoolSeal™ Trinity is a bipolar electrosurgical instrument intended for use in minimally invasive or open surgical procedures where ligation and division of vessels, tissue bundles, and lymphatics is desired. The CoolSeal™ Trinity can be used on arteries up to and including 6 mm, veins, and vascular bundles up to and including 7 mm in diameter.It is indicated for use in general surgery procedures including urologic, vascular, and gynecologic.
The CoolSeal™ Trinity has not been shown to be effective for tubal sterilization or tubal coagulation for sterilization procedures. Do not use the CoolSeal™ Trinity for these procedures.
CoolSeal™ Mini:
5
The CoolSeal™ Mini is intended for use in open and laparoscopic general surgical procedures to seal blood vessels and vascular bundles up to and including 5 mm in diameter for use in adult and pediatric populations, wherever vessel ligation is required.
The device is contraindicated for use in ENT procedures.
COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICES
This premarket notification contains three major components that make up the CoolSeal™ vessel sealing system. The predicates identified in this submission were identified for each major component to better demonstrate substantial equivalence with similar performing components. These are as follows (Subject Device/Predicate Device):
- · The CoolSeal™ Generator / The JustRight™ Generator both components are designed to provide lower power bipolar Radio Frequency (RF) energy to bipolar vessel sealing instruments for tissue-sealing applications. Both generators provide multiples signals (lights and tones) to users of the vessel sealing device related to the clinical function (e.g., seal complete, incomplete seal). The main difference between the subject device and the predicate device is the subject device has the ability to operate with multiple bipolar vessel sealing instruments. The subject device will automatically detect the compatible instrument and adjust the energy delivery algorithm accordingly. The predicate generator was only compatible with a single sealer.
- · The CoolSeal™ Trinity / Ligasure™ Maryland jaw Sealer/Divider One-Step Sealing, Nano-Coated - both devices rely on the application of radio frequency (RF) energy to target tissue to create seals in the same sized structures (up to and including 7 mm in vasculature, tissue bundles, and lymphatics) interposed between the jaws of the instrument. At a high level, the subject device and predicate device is based on the following same technological elements:
- Jaws used to grasp, dissect, and manipulate tissue including sealing of intended o structures.
- Lever used to open and close the jaws. o
- Activation button allows the user to activate RF energy for sealing applications. O
- Cutting trigger allows the user to divide (cut) sealed structures O
- Shaft multiple shaft sizes available O
The following technological differences exist between the subject and predicate devices:
- o Bilateral jaws
- o Activation button is thumb activated vs lever activated
- o Lower power output level required for sealing of structures
- · The CoolSeal™ Mini / JustRight™ Sealer The CoolSeal™ Mini is the JustRight™ Sealer with some minor design modifications to enable its compatibility with the CoolSeal™ Generator. Excluding the following technological differences, the CoolSeal™ Mini is identical to the JustRight™ Sealer
- o Connector (plug) the connector was swapped out from the predicate device to enable compatibility with the CoolSeal™ Generator
- 0 Aesthetics non-patient contacting components were modified to reflect the new CoolSeal™ brand
6
PERFORMANCE DATA
The following performance data were provided in support of the substantial equivalence determination.
Biocompatibility Testing
CoolSeal™ Trinity:
The biocompatibility evaluation for the CoolSeal™ Trinity was conducted in accordance with ISO 10993-1:2018, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process," as recognized by FDA.
CoolSeal™ Mini:
The design changes made to the predicate device to create the CoolSeal™ Mini does not impact any of the patient contacting material. Therefore, the Biocompatibility testing previously submitted for the predicate device is still applicable to the CoolSeal™ Mini.
Electrical Safety and Electromagnetic Compatibility (EMC)
The CoolSeal™ system complies with relevant clauses of the ANSI/AAMI/ES 60601-1:2005/(R)2012 and A1:2012 and IEC 60601-2-2:2017 standards for electrical safety and IEC 60601-1-2:2014 standard for EMC.
Mechanical and Functional Testing
Mechanical, electrical, and functional testing was carried out to verify that the proposed device performed as expected.
Ex-vivo and In-vivo Vessel Burst Pressure
CoolSeal™ Trinity:
Ex-vivo burst pressure testing of excised fresh porcine blood vessels was conducted on the subject device and predicate device to demonstrate equivalent bipolar electrosurgical vessel sealing performance. Additionally, in-vivo burst pressure testing of lymphatics was conducted on the subject device for comparison to the predicate to device to demonstrate equivalent bipolar electrosurgical vessel sealing performance.
CoolSeal™ Mini:
Ex-vivo burst pressure testing of excised fresh porcine blood vessels was conducted on the subject device and predicate device to demonstrate bipolar electrosurgical vessel sealing performance.
In-vivo Thermal Spread Comparison
CoolSeal™ Trinity:
Open laparotomy was performed in a porcine model using the subject device and predicate device. Each device was used to seal vessels and tissue bundles. Samples were excised for threedimensional histological assessments (e.g., length, width, and depth) to quantify thermal spread in seals created by both devices. This study demonstrated that the subject device is as safe and effective as the predicate device.
7
Image /page/7/Picture/2 description: The image shows the logo for Bolder Surgical. The word "BOLDER" is written in a large, sans-serif font, with the "O" replaced by a circle with a small, black, diamond shape inside. Below the word "BOLDER" is the word "SURGICAL" in a smaller, sans-serif font. The text is a dark blue color, and the background is white.
CoolSeal™ System Traditional 510(k) Submission
Chronic Animal Study
CoolSeal™ Trinity:
A chronic study was conducted to assess safety and performance of bipolar vessel sealing with the subject device over the course of 28 days. All animals survived 28 days post-op without any complications. All vessel sealing effects on tissue maintained chronic hemostasis and healed as anticipated.
Clinical Studies
Clinical data was not necessary to support this premarket notification as the indications for use, device technology, and mechanism of action is not significantly different when compared to the predicate devices. Furthermore, nonclinical testing as described above is sufficient to establish substantial equivalence.
CONCLUSIONS
Based on a review of bench top assessments, comparison of the device classification, intended use, operating principles, technological characteristics, sterility, and biocompatibility, the subject devices are safe, as effective, and performs as well as the legally marketed predicate devices.